Position in AMGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$3,953,264
+$17,822 QoQ
Shares Held
10,917
-2.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.97%
of 13F equity value
Holder Rank
#945
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hanson & Doremus Investment Management holds $28,323,234 across 13 Drug Manufacturers - General names. AMGN ranks #5 (14.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
56,094 | $7,208,079 | |
| 2 | LLY |
ELI LILLY & Co
|
3,655 | $4,383,917 | |
| 3 | ABBV |
AbbVie Inc.
|
16,581 | $4,172,442 | |
| 4 | JNJ |
Johnson & Johnson
|
16,303 | $4,140,472 | |
| 5 | AMGN |
Amgen Inc
This page
|
10,917 | $3,953,264 | |
| 6 | AZN |
Astrazeneca PLC
|
5,916 | $1,121,791 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
18,157 | $1,046,206 | |
| 8 | PFE |
Pfizer Inc
|
35,388 | $852,143 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,953,264 | 10,917 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $3,935,442 | 11,185 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $3,615,793 | 11,047 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $3,204,945 | 11,357 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $3,168,195 | 11,347 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $3,092,133 | 9,925 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $396,172 | 1,520 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $489,759 | 1,520 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $497,420 | 1,592 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $436,999 | 1,537 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $414,460 | 1,439 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $386,745 | 1,439 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $319,486 | 1,439 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $347,878 | 1,439 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $469,337 | 1,787 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $324,350 | 1,439 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $350,108 | 1,439 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $347,978 | 1,439 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $190,999 | 849 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $180,539 | 849 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $211,818 | 869 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $240,101 | 965 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $218,194 | 949 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $220,865 | 869 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $204,962 | 869 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $192,390 | 949 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||